EA201492081A1 - (r)-нифурател, его применение в лечении инфекций и синтез (r)- и (s)-нифуратела - Google Patents

(r)-нифурател, его применение в лечении инфекций и синтез (r)- и (s)-нифуратела

Info

Publication number
EA201492081A1
EA201492081A1 EA201492081A EA201492081A EA201492081A1 EA 201492081 A1 EA201492081 A1 EA 201492081A1 EA 201492081 A EA201492081 A EA 201492081A EA 201492081 A EA201492081 A EA 201492081A EA 201492081 A1 EA201492081 A1 EA 201492081A1
Authority
EA
Eurasian Patent Office
Prior art keywords
nifural
nifuratel
infections
synthesis
treatment
Prior art date
Application number
EA201492081A
Other languages
English (en)
Inventor
Стефания Гаглиарди
Алессандра Консонни
Федерико Майлланд
Анна Булгерони
Original Assignee
Полихем Са
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47846051&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA201492081(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Полихем Са filed Critical Полихем Са
Publication of EA201492081A1 publication Critical patent/EA201492081A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C241/00—Preparation of compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C07C241/02—Preparation of hydrazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/26—Oxygen atoms attached in position 2 with hetero atoms or acyl radicals directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings

Abstract

В заявленном изобретении раскрыт (R)-нифурател, а также его применение в качестве бактерицидного и бактериостатического агента, а также фармацевтические композиции с его содержанием; неожиданным результатом явился тот факт, что (R)-нифурател имеет лучший противомикробный профиль, чем нифурател рацемат или (S)-нифурател. Также заявлен новый процесс синтеза (R)-нифуратела и (S)-нифуратела.
EA201492081A 2012-05-11 2013-03-13 (r)-нифурател, его применение в лечении инфекций и синтез (r)- и (s)-нифуратела EA201492081A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20120167640 EP2662371A1 (en) 2012-05-11 2012-05-11 (R)-Nifuratel and synthesis of (R) and (S)-Nifuratel
PCT/EP2013/055078 WO2013167295A1 (en) 2012-05-11 2013-03-13 (r) -nifuratel, its use for the treatment of infections and synthesis of (r) and (s) -nifuratel

Publications (1)

Publication Number Publication Date
EA201492081A1 true EA201492081A1 (ru) 2015-06-30

Family

ID=47846051

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201492081A EA201492081A1 (ru) 2012-05-11 2013-03-13 (r)-нифурател, его применение в лечении инфекций и синтез (r)- и (s)-нифуратела

Country Status (27)

Country Link
US (2) US9284306B2 (ru)
EP (2) EP2662371A1 (ru)
JP (1) JP2015515998A (ru)
KR (1) KR20150008871A (ru)
CN (1) CN104379580A (ru)
AU (1) AU2013258385A1 (ru)
BR (1) BR112014027953A2 (ru)
CA (1) CA2869827A1 (ru)
CL (1) CL2014002951A1 (ru)
CO (1) CO7131368A2 (ru)
CR (1) CR20140505A (ru)
DO (1) DOP2014000252A (ru)
EA (1) EA201492081A1 (ru)
EC (1) ECSP14026432A (ru)
GE (2) GEP201706626B (ru)
HK (1) HK1202539A1 (ru)
IL (1) IL235429A0 (ru)
IN (1) IN2014DN09256A (ru)
MA (1) MA20150279A1 (ru)
MX (1) MX2014013759A (ru)
NZ (1) NZ700752A (ru)
PE (1) PE20150167A1 (ru)
PH (2) PH12014502500B1 (ru)
SG (2) SG11201406447SA (ru)
TN (1) TN2014000430A1 (ru)
WO (1) WO2013167295A1 (ru)
ZA (1) ZA201407596B (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108254453A (zh) * 2016-12-28 2018-07-06 苏州电器科学研究院股份有限公司 一种有效测定塑料制品中邻苯二甲酸酯含量的检测方法
BR112020004307A2 (pt) 2017-09-20 2020-11-10 Ph Pharma Co., Ltd. análogos de tailanestatina
CN108760950B (zh) * 2018-04-25 2022-07-15 国检测试控股集团京诚检测有限公司 一种测定硝基呋喃代谢物的方法
CN111892557B (zh) * 2019-05-05 2022-11-08 河北圣泰材料股份有限公司 哌嗪类成膜离子液体的合成方法
CN110672765B (zh) * 2019-10-11 2022-03-18 温州海鹤药业有限公司 一种定量检测硝呋太尔中顺式异构体杂质的方法
CN112457304B (zh) * 2020-12-07 2022-03-11 中国药科大学 一种硝呋太尔的制备方法
CN113828243B (zh) * 2021-09-14 2022-06-28 南京南大药业有限责任公司 一种硝呋太尔制霉菌素栓制造方法及设备

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE635608A (ru) 1962-08-01
CN100506820C (zh) 2006-03-16 2009-07-01 韩志强 (s)-硝呋太尔,其制备方法和应用
CN100516063C (zh) * 2006-03-16 2009-07-22 韩志强 硝呋太尔的生产方法
CN101434584A (zh) * 2007-11-15 2009-05-20 中山大学 具有抗菌活性的手性噁唑烷酮类化合物
EP2243482A1 (en) * 2009-04-20 2010-10-27 Polichem SA Use of nifuratel to treat infections caused by atopobium species

Also Published As

Publication number Publication date
NZ700752A (en) 2016-02-26
HK1202539A1 (en) 2015-10-02
US9284306B2 (en) 2016-03-15
CO7131368A2 (es) 2014-12-01
BR112014027953A2 (pt) 2018-02-06
IN2014DN09256A (ru) 2015-07-10
US20150148547A1 (en) 2015-05-28
TN2014000430A1 (en) 2016-03-30
US20150119431A1 (en) 2015-04-30
PH12014502500A1 (en) 2014-12-15
GEP201706626B (en) 2017-02-10
MA20150279A1 (fr) 2015-08-31
EP2662371A1 (en) 2013-11-13
ZA201407596B (en) 2016-05-25
WO2013167295A1 (en) 2013-11-14
SG10201608485XA (en) 2016-12-29
JP2015515998A (ja) 2015-06-04
AU2013258385A1 (en) 2014-10-30
PH12015502241A1 (en) 2016-08-15
US9067927B2 (en) 2015-06-30
DOP2014000252A (es) 2014-12-31
CR20140505A (es) 2015-02-06
CN104379580A (zh) 2015-02-25
PH12014502500B1 (en) 2014-12-15
IL235429A0 (en) 2014-12-31
SG11201406447SA (en) 2014-11-27
CA2869827A1 (en) 2013-11-14
KR20150008871A (ko) 2015-01-23
MX2014013759A (es) 2015-08-07
GEP201606595B (en) 2017-01-10
EP2847189A1 (en) 2015-03-18
CL2014002951A1 (es) 2014-12-26
ECSP14026432A (es) 2015-09-30
PE20150167A1 (es) 2015-02-07

Similar Documents

Publication Publication Date Title
EA201492081A1 (ru) (r)-нифурател, его применение в лечении инфекций и синтез (r)- и (s)-нифуратела
EA201692301A1 (ru) Производные бороновой кислоты и их терапевтическое применение
UA116648C2 (uk) Фумарати як проліки та їх застосування при лікуванні різних захворювань
EA201591003A1 (ru) Производные бороновой кислоты и их терапевтическое применение
EA201591004A1 (ru) Производные бороновой кислоты и их терапевтическое применение
EA201691988A1 (ru) Производные бороновой кислоты и их терапевтическое применение
EA201400838A1 (ru) ЗАМЕЩЕННЫЕ АМИДИНОМ β-ЛАКТАМЫ, ИХ ПОЛУЧЕНИЕ И ПРИМЕНЕНИЕ В КАЧЕСТВЕ АНТИБАКТЕРИАЛЬНЫХ СРЕДСТВ
DOP2016000253A (es) Nuevos compuestos
GEP201606598B (en) Heteroaromatic compounds as dopamine d1 ligands
EA201591618A1 (ru) Замещенные имидазопиридазины
GEP201706725B (en) Compounds and compositions as inhibitors of mek
EA201490688A1 (ru) 2-тиопиримидиноны
EA201791174A1 (ru) Антимикотическое соединение
EA201600434A1 (ru) Применение производных бензимидазолпролина
EA201690183A1 (ru) Замещенные пиразолопиридинамины
EA201892822A1 (ru) Новые антибактериальные соединения
EA201690783A1 (ru) Вещества, фармацевтическая композиция и методы применения при лечении воспалительных заболеваний
EA201790070A1 (ru) Бифениламиды, содержащие модифицированные простые эфирные группы, в качестве ингибиторов hsp90 и стимуляторов hsp70
EA201501187A1 (ru) Новые химические соединения (варианты) и их применение для лечения онкологических заболеваний
WO2015066302A3 (en) Compositions, methods of use, and methods of treatment
DOP2016000251A (es) Inhibidores de las vías de señalización de wnt
EA201591717A1 (ru) Твердые формы гидрохлорида вемурафениба
EA201591507A1 (ru) Лечение рассеянного склероза лахинимодом
EA201890419A1 (ru) ОТСЕЛЕКТИРОВАННЫЙ АМИД γ-ГИДРОКСИМАСЛЯНОЙ КИСЛОТЫ И ЕГО ПРИМЕНЕНИЯ ПРИ ЛЕЧЕНИИ ЗЛОУПОТРЕБЛЕНИЯ АЛКОГОЛЕМ
EA201591180A1 (ru) Составы ингибитора lfa-1